Michigan Pathology ✓

@UMichPath · Ann Arbor, MI · joined 13 Mar 2017

The University of Michigan Department of Pathology is comprised of nearly 200 faculty and 1,100 staff, who provide the best patient care and research possible.

12 721Followers

1 957Following

6 899Posts total

5.8KViews on collected posts

Latest posts

Michigan Pathology ✓@UMichPath14 Sep

📣 Help Us Connect with Our U-M Pathology Alumni #UMichPath is updating our alumni database as we prepare to launch a new alumni newsletter and expand opportunities to stay connected with you! If you are a former resident or fellow, please update your contact information. By ht

441 views · 2 likes · 1 reposts · 1 replies Open on X →

Michigan Pathology ✓@UMichPath10 Sep

Please join us in congratulating Dr. Joanna Lum on defending her thesis! Her research in the @vennetilab explored how lactate and epigenetics shape diffuse midline glioma, an aggressive pediatric brain cancer. Read more: https://t.co/3eEhldhiJP https://t.co/UAQJDY6SvP

664 views · 7 likes · 3 reposts · 0 replies Open on X →

Michigan Pathology ✓@UMichPath8 Sep

Meet Nathan Ryan, MD, MS, a new pathology resident whose love for histology started long before residency. After years in research, he found his way to pathology, and now he’s excited to spend the next chapter learning, teaching, and looking at those “nice pinks and purples” htt

737 views · 5 likes · 2 reposts · 0 replies Open on X →

Michigan Pathology ✓@UMichPath8 Sep

🌎 Global health leaders are coming together at the GPALM Consortium 2026 Summit! Join us on Nov. 13 at #UMichPath for conversations advancing global pathology & laboratory medicine. 📍 NCRC, University of Michigan 📝 Registration now open 🧪 CME Credit Available 🍽️ Lunch https://t

402 views · 0 likes · 0 reposts · 0 replies Open on X →

Michigan Pathology ✓@UMichPath25 Nov 2025

Congratulations to #UMichPath researchers, Drs. Jolanta Grembecka and Tomasz Cierpicki on their recent @US_FDA approval of the first once-daily oral therapy for relapsed/refractory NPM1-mutant acute myeloid leukemia. “This transformative discovery, grounded in research https://

3.6K views · 23 likes · 2 reposts · 1 replies Open on X →

Against accounts of the same size

4 posts from the last 90 days, next to the 10K–100K follower range. ordinary reach for its size, weaker reaction than most.

Median views552this account924median for 10K–100K

Reach, %4.34%this account3.62%median for 10K–100K

Engagement, %0.93%this account1.52%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	552	924	0.60×
Reach (views ÷ followers)	4.34%	3.62%	1.20×
Engagement rate	0.93%	1.52%	0.61×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.6K25 Nov

4028 Sep

737

66410 Sep

44114 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.75%25 Nov

0.25%8 Sep

0.95%

1.51%10 Sep

0.91%14 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes71.2%37 in total

Reposts15.4%8 in total

Replies3.8%2 in total

Quotes3.8%2 in total

Bookmarks5.8%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.